The chemical class known as PP2A-B55-γ Activators refers to a collection of compounds that specifically target and enhance the activity of the PP2A-B55-γ holoenzyme complex. PP2A, or Protein Phosphatase 2A, is a crucial serine/threonine phosphatase in eukaryotic cells, involved in a multitude of cellular processes. Its activity and specificity are governed by the association with various regulatory subunits, one of which is the B55-γ subunit. Activators of this complex are thought to modulate the phosphatase activity of PP2A, influencing the dephosphorylation of specific substrates that the B55-γ subunit directs PP2A towards. The chemical activators might achieve this by either stabilizing the active conformation of the phosphatase core, enhancing its interaction with the B55-γ subunit, or increasing the affinity of the holoenzyme complex for its substrates.
These activators encompass a range of chemical structures, reflecting the diversity required to interact with a protein complex of this nature. The complexity of the PP2A-B55-γ structure necessitates that activators must be able to navigate the regulatory subunit to exert their effects on the catalytic core. The molecular mechanisms of action for these activators can vary significantly. Some might mimic endogenous molecules that naturally enhance PP2A-B55-γ activity, while others might represent novel scaffolds that have been identified through high-throughput screening and subsequent optimization. These compounds bind to specific sites on the PP2A-B55-γ complex, potentially inducing conformational changes that lead to enhanced phosphatase activity. By modulating the function of PP2A-B55-γ, these activators can have profound effects on the cellular pathways regulated by this phosphatase complex. The development and study of PP2A-B55-γ activators contribute significantly to the biochemical understanding of this phosphatase complex and provide valuable tools for dissecting its role in cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
Fingolimod is known to increase PP2A activity, though its specificity for different subunits is not fully clear. | ||||||
D-erythro-Sphingosine | 123-78-4 | sc-3546 sc-3546A sc-3546B sc-3546C sc-3546D sc-3546E | 10 mg 25 mg 100 mg 1 g 5 g 10 g | $88.00 $190.00 $500.00 $2400.00 $9200.00 $15000.00 | 2 | |
Sphingosine can activate PP2A, similar to other sphingolipids. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin can affect multiple cellular pathways, including potential modulation of PP2A activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
This polyphenol has been reported to activate PP2A in certain cellular contexts. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
This omega-3 fatty acid can modulate PP2A activity. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $92.00 $206.00 $1744.00 $7864.00 $16330.00 | 11 | |
Like EPA, DHA can also affect PP2A function. | ||||||
C2 Ceramide | 3102-57-6 | sc-201375 sc-201375A | 5 mg 25 mg | $77.00 $316.00 | 12 | |
Ceramide has been reported to activate PP2A, but it's worth noting that its cellular effects are multifaceted. | ||||||
Perphenazine | 58-39-9 | sc-208161 | 100 mg | $190.00 | ||
This antipsychotic drug has been suggested to activate PP2A in specific settings. | ||||||